Geleen-eindhoven-leiden

Dutch Public-Private Partnership Invests 28 Million Euro on Research Into Personalized Medicine

Older News

GELEEN-EINDHOVEN-LEIDEN, The Netherlands, February 15, 2010 - The Netherlands' three Top Institutes for life-science research (the BioMedical Materials program, the Center for Translational Molecular Medicine and Top Institute Pharma) today announced a joint investment of MEUR 28 on innovative research targeted at bringing personalized medicine closer to reality.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy